Key facts
- Enhanced Fertility’s last known valuation is $16.1M (Mar 2025).
- It has raised $2.4M; the latest was Later Stage VC in Nov 2025.
- Notable investors include Innovate UK, Startupbootcamp Holding, Unicorn Factory Lisboa, Eagle Venture Fund, BioIndustry Association — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Enhanced Fertility
- ·The full record, as it builds
Funding rounds
No funding rounds for Enhanced Fertility are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Enhanced Fertility
Developer of a digital fertility care platform intended to improve diagnosis accuracy and treatment outcomes. The company's platform leverages data, artificial intelligence, and remote diagnostics, enabling fertility clinics to automate screening, improve diagnostic accuracy, and personalize treatment protocols to maximize treatment success rates.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2020
- Employees
- 13
- Website
- efp.clinic/
- Ownership
- Privately Held (backing)
Enhanced Fertility doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Enhanced Fertility shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Enhanced Fertility in its N-PORT filings yet. We sweep new filings monthly.